Mycobacterium tuberculosis Decreases Human Macrophage IFN-γ Responsiveness through miR-132 and miR-26a

IFN-γ–activated macrophages play an essential role in controlling intracellular pathogens; however, macrophages also serve as the cellular home for the intracellular pathogen Mycobacterium tuberculosis. Based on previous evidence that M. tuberculosis can modulate host microRNA (miRNA) expression, we examined the miRNA expression profile of M. tuberculosis–infected primary human macrophages. We identified 31 differentially expressed miRNAs in primary human macrophages during M. tuberculosis infection by NanoString and confirmed our findings by quantitative real-time RT-PCR. In addition, we determined a role for two miRNAs upregulated upon M. tuberculosis infection, miR-132 and miR-26a, as negative regulators of transcriptional coactivator p300, a component of the IFN-γ signaling cascade. Knockdown expression of miR-132 and miR-26a increased p300 protein levels and improved transcriptional, translational, and functional responses to IFN-γ in human macrophages. Collectively, these data validate p300 as a target of miR-132 and miR-26a, and demonstrate a mechanism by which M. tuberculosis can limit macrophage responses to IFN-γ by altering host miRNA expression.

[1]  S. Dhandayuthapani,et al.  Differential expression of miRNAs by macrophages infected with virulent and avirulent Mycobacterium tuberculosis. , 2013, Tuberculosis.

[2]  J. Schreiber,et al.  MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. , 2013, The Journal of clinical investigation.

[3]  Fei Zhai,et al.  miR-582-5p Is Upregulated in Patients with Active Tuberculosis and Inhibits Apoptosis of Monocytes by Targeting FOXO1 , 2013, PloS one.

[4]  Jinli Wang,et al.  MicroRNA-155 Promotes Autophagy to Eliminate Intracellular Mycobacteria by Targeting Rheb , 2013, PLoS pathogens.

[5]  D. Chauhan,et al.  Current understanding on micro RNAs and its regulation in response to Mycobacterial infections , 2013, Journal of Biomedical Science.

[6]  M. Nireekshan Kumar,et al.  Identification of a novel role of ESAT‐6‐dependent miR‐155 induction during infection of macrophages withMycobacterium tuberculosis , 2012, Cellular microbiology.

[7]  Leon N. Schulte,et al.  The mammalian microRNA response to bacterial infections , 2012, RNA biology.

[8]  S. Gagneux Host–pathogen coevolution in human tuberculosis , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[9]  Murugesan V. S. Rajaram,et al.  Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b , 2011, Proceedings of the National Academy of Sciences.

[10]  Xiongfei Xu,et al.  The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ , 2011, Nature Immunology.

[11]  Xinjing Wang,et al.  Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. , 2011, Molecular immunology.

[12]  S. Gordon,et al.  Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry , 2011, Immunological reviews.

[13]  Murugesan V. S. Rajaram,et al.  NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages , 2011, Cellular microbiology.

[14]  Murugesan V. S. Rajaram,et al.  Mycobacterium tuberculosis Activates Human Macrophage Peroxisome Proliferator-Activated Receptor γ Linking Mannose Receptor Recognition to Regulation of Immune Responses , 2010, The Journal of Immunology.

[15]  U. Schaible,et al.  Optimisation of Bioluminescent Reporters for Use with Mycobacteria , 2010, PloS one.

[16]  Frances Gotch,et al.  miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator , 2010, Nature Cell Biology.

[17]  V. Lafont,et al.  The IFNgamma-induced STAT1-CBP/P300 association, required for a normal response to the cytokine, is disrupted in Brucella-infected macrophages. , 2009, Microbial pathogenesis.

[18]  S. Snyder,et al.  Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis , 2008, Nature Cell Biology.

[19]  A. Azad,et al.  Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. , 2008, Journal of immunology.

[20]  A. Azad,et al.  The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis , 2005, The Journal of experimental medicine.

[21]  L. Platanias Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.

[22]  Michael C. Ostrowski,et al.  The Serine/Threonine Kinase Akt Promotes Fcγ Receptor-mediated Phagocytosis in Murine Macrophages through the Activation of p70S6 Kinase* , 2004, Journal of Biological Chemistry.

[23]  Z. Darieva,et al.  Activation of phosphatidylinositol 3‐kinase and c‐Jun‐N‐terminal kinase cascades enhances NF‐κB‐dependent gene transcription in BCG‐stimulated macrophages through promotion of p65/p300 binding , 2004, Journal of leukocyte biology.

[24]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[25]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[26]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[27]  Chilakamarti V. Ramana,et al.  Stat1-dependent and -independent pathways in IFN-γ-dependent signaling , 2002 .

[28]  G. Stark,et al.  Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. , 2002, Trends in immunology.

[29]  S. Roy,et al.  ERK1 and ERK2 Activate CCAAAT/Enhancer-binding Protein-β-dependent Gene Transcription in Response to Interferon-γ* , 2001, The Journal of Biological Chemistry.

[30]  R. Schreiber,et al.  ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. , 2001, The Journal of biological chemistry.

[31]  L. Ting,et al.  Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.

[32]  H. Etlinger,et al.  the Journal of Immunology , 2006 .

[33]  S. Dorman,et al.  Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. , 1998, The Journal of clinical investigation.

[34]  M. Fenton Macrophages and tuberculosis , 1998, Current opinion in hematology.

[35]  J. Casanova,et al.  Infections in IFNGR-1-deficient children. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[36]  M. Newport,et al.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.

[37]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[38]  L. Schlesinger Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. , 1993, Journal of immunology.

[39]  M. Horwitz,et al.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.

[40]  Á. Ruibal,et al.  High level of interferon gamma in tuberculous pleural effusion. , 1988, Chest.

[41]  B. Champion,et al.  Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. , 1986, Immunology.

[42]  M. Horwitz,et al.  Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. , 1980, The Journal of clinical investigation.